Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Jan M. Keppel Hesselink, MD, PhD is professor of molecular pharmacology at the university of Witten/Herdecke (Germany). He was elected as Fellow of the Pharmaceutical Faculty in Medicine (FFPM) in the UK. He worked several years at Bayer AG in Germany as VP CNS and business head CNS. He was advisor R&D and business strategies to the Dutch Royal Acadamy of Science (KNAW). Currently he is a consultant for life science companies and investors, founder of the Chonic Pain Coalition and of the Institute for Neuropathic Pain. His current focus is topical analgesic cream development and endocannabinoids as analgesics.
Dr. Jan M. Keppel Hesselink current focus is topical analgesic cream development and endocannabinoids as analgesics.
|Jan M Keppel Hesselink and David J Kopsky|
|Review Article: J Pain Relief 2017, 7:313|
|Jan MK Hesselink and David J Kopsky|
|Case Report: J Pain Relief 2016, 6:284|
|Jan M Keppel Hesselink|
|Editorial: Clin Res Foot Ankle 2014, 3: e105|
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals